ANJU LAXMAN: Open Payments
NPI 1437641792 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 16 payments from 8 companies in 2025. Trend: 2023 $252 · 2024 $264 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $135 |
| Amgen Inc. | 4 | $97 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Inspire Medical Systems, Inc. | 3 | $77 |
| Lilly USA, LLC | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: Kerendia, INSPIRE, OTEZLA, VERQUVO, MOUNJARO, REPATHA, AIRSUPRA, NEXLETOL.
Industry payments across TX — which companies pay providers there.
